San Jose, CA, United States of America

Geoffrey A Barrall

This inventor holds 20 USPTO granted patents and 3 published patent applications, primarily in Nanopore Technology. Top assignees: Electronic Biosciences, Inc., Roche Sequencing Solutions, Inc., Electronics Biosciences, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey A Barrall. Retrieved from https://idiyas.com/inventor/geoffrey-a-barrall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 95.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • San Diego, CA (US) (2002 - 2023)
  • San Jose, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Areas of Expertise:
Nanopore Devices
Protein Incorporation
Bilayer Formation
Osmotic Imbalance
Signal Processing
Alpha Hemolysin
Chemically Modified Polypeptides
Voltage-Induced Incorporation
Sequencing Cell
High Contrast Devices
Polymer Interactions
Nuclear Quadrupole Resonance
20 patents (USPTO):Explore Patents

Title: Innovations by Geoffrey A. Barrall: Pioneering Osmotic Imbalance Techniques

Introduction

Geoffrey A. Barrall, a notable inventor based in San Jose, California, has made significant contributions to the field of biophysics and sequencing technology with a remarkable portfolio of 19 patents. His innovative work primarily focuses on methods that utilize osmotic imbalance for advanced bilayer formation, which are crucial in the development of nanopore-based sequencing chips.

Latest Patents

Among his latest patents, two innovative methods stand out. The first patent details “Osmotic imbalance methods for bilayer formation,” which discloses a method for creating lipid bilayers over cell arrays in sequencing chips. This process involves the careful manipulation of salt buffer solutions to create osmotic imbalances that allow for the precise deposition of lipid membranes. The second patent titled “Removing and reinserting protein nanopores in a membrane using osmotic imbalance” describes techniques for replacing nanopores within a sequencing chip. This method introduces an osmotic imbalance to change the membrane's shape, facilitating the ejection of existing nanopores and the insertion of new ones without damaging the membrane.

Career Highlights

Throughout his career, Geoffrey has worked with reputable companies, including Electronic Biosciences, Inc. and Roche Sequencing Solutions, Inc. His experience in these organizations has significantly shaped his expertise in biotechnological advancements, particularly in the realm of nanopore sequencing technology.

Collaborations

Geoffrey Barrall has collaborated with talented individuals like Eric N. Ervin and Jason Komadina, contributing to a wealth of knowledge and innovation within his field. His collaborative efforts emphasize the importance of teamwork in driving technological advancements and refining innovative methods.

Conclusion

Geoffrey A. Barrall's contributions through his patents and collaborative work highlight his crucial role in advancing nanotechnology and biophysics. His innovative techniques concerning osmotic imbalances are paving the way for more efficient and effective sequencing technologies, reflecting his dedication to innovation and excellence in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…